X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
DM | 2024-11-13 | CPRX | McEnany Patrick J | Chairman of Board of Directors | S - Sale+OE | $22.58 | -137,155 | 4,478,169 | -3% | -$3,096,801 | |||||
DM | 2024-11-11 | CPRX | McEnany Patrick J | Chairman of Board of Directors | S - Sale+OE | $23.39 | -492,000 | 4,478,169 | -10% | -$11,510,102 | |||||
D | 2024-08-21 | CPRX | Tierney David S | Dir | S - Sale+OE | $20.10 | -15,000 | 348,874 | -4% | -$301,455 | |||||
2024-08-20 | CPRX | Miller Steve | Chief Op., Scientific Officer | S - Sale | $20.35 | -150,000 | 675,124 | -18% | -$3,052,900 | ||||||
D | 2024-08-09 | CPRX | Del Carmen Jeffrey | Chief Commercial Officer | S - Sale+OE | $18.42 | -36,058 | 12,369 | -74% | -$664,310 | |||||
D | 2024-08-09 | CPRX | Ingenito Gary | Chief Med., Reg. Officer | S - Sale+OE | $18.04 | -100,000 | 51,391 | -66% | -$1,804,000 | |||||
2024-06-07 | CPRX | Del Carmen Jeffrey | Chief Commercial Officer | S - Sale | $16.07 | -7,541 | 18,427 | -29% | -$121,184 | ||||||
D | 2024-06-05 | CPRX | Ingenito Gary | Chief Med., Reg. Officer | S - Sale+OE | $16.16 | -80,000 | 51,391 | -61% | -$1,292,800 | |||||
D | 2024-06-04 | CPRX | Daly Richard J | Pres, CEO | S - Sale+OE | $15.98 | -17,323 | 234,824 | -7% | -$276,735 | |||||
2024-06-03 | CPRX | Harper Molly | Dir | S - Sale | $16.30 | -5,333 | 0 | -100% | -$86,949 | ||||||
D | 2024-04-08 | CPRX | Tierney David S | Dir | S - Sale+OE | $15.68 | -25,000 | 348,874 | -7% | -$392,000 | |||||
2024-03-27 | CPRX | Elsbernd Brian | Chief Compliance, Legal Office | S - Sale | $16.44 | -25,000 | 124,433 | -17% | -$411,000 | ||||||
D | 2023-12-15 | CPRX | Harper Molly | Dir | S - Sale+OE | $14.39 | -14,000 | 0 | -100% | -$201,420 | |||||
D | 2023-12-12 | CPRX | Tierney David S | Dir | S - Sale+OE | $13.33 | -50,000 | 333,541 | -13% | -$666,250 | |||||
DM | 2023-12-08 | CPRX | Grande Alicia | VP, Treasurer, CFO | S - Sale+OE | $13.97 | -100,000 | 50,557 | -66% | -$1,396,780 | |||||
D | 2023-12-06 | CPRX | Ingenito Gary | Chief Med., Reg. Officer | S - Sale+OE | $14.02 | -50,000 | 38,367 | -57% | -$701,000 | |||||
2023-12-05 | CPRX | Miller Steve | Chief Op., Scientific Officer | S - Sale | $14.24 | -40,000 | 647,457 | -6% | -$569,600 | ||||||
D | 2023-05-15 | CPRX | McEnany Patrick J | Pres, CEO | S - Sale+OE | $13.23 | -26,151 | 4,119,285 | -1% | -$345,978 | |||||
D | 2023-04-05 | CPRX | Tierney David S | Dir | S - Sale+OE | $16.83 | -30,000 | 313,541 | -9% | -$504,900 | |||||
D | 2023-03-29 | CPRX | Del Carmen Jeffrey | Chief Commercial Officer | S - Sale+OE | $16.70 | -40,000 | 7,541 | -84% | -$667,810 | |||||
DM | 2023-03-28 | CPRX | Grande Alicia | VP, Treasurer, CFO | S - Sale+OE | $16.61 | -108,216 | 50,557 | -68% | -$1,797,886 | |||||
D | 2023-03-22 | CPRX | Grande Alicia | VP, Treasurer, CFO | S - Sale+OE | $16.50 | -41,784 | 50,557 | -45% | -$689,528 | |||||
D | 2023-03-20 | CPRX | Elsbernd Brian | Chief Compliance, Legal Office | S - Sale+OE | $16.07 | -50,000 | 138,076 | -27% | -$803,450 | |||||
D | 2022-12-06 | CPRX | Ingenito Gary | Chief Medical Officer | S - Sale+OE | $16.85 | -5,918 | 30,802 | -16% | -$99,718 | |||||
2022-11-22 | CPRX | Grande Alicia | VP, Treasurer, CFO | S - Sale | $16.53 | -120,000 | 27,442 | -81% | -$1,983,240 | ||||||
M | 2022-11-21 | CPRX | Miller Steve | COO | S - Sale | $15.69 | -100,000 | 553,791 | -15% | -$1,568,820 | |||||
M | 2022-11-21 | CPRX | Coelho Philip H | Dir | S - Sale | $15.87 | -100,000 | 149,553 | -40% | -$1,586,750 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |